Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial-Reference-Cited by-同舟云学术

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

Published:2009-10 Issue:9697 Volume:374 Page:1243-1251
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Chlebowski Rowan T,Schwartz Ann G,Wakelee Heather,Anderson Garnet L,Stefanick Marcia L,Manson JoAnn E,Rodabough Rebecca J,Chien Jason W,Wactawski-Wende Jean,Gass Margery,Kotchen Jane Morley,Johnson Karen C,O'Sullivan Mary Jo,Ockene Judith K,Chen Chu,Hubbell F Allan

Publisher

Elsevier BV

Subject

General Medicine

Reference45 articles.

1. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial;Rossouw;JAMA,2002

2. Estrogen plus progestin influence on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial;Chlebowski;JAMA,2003

3. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial;Cauley;JAMA,2003

4. Estrogen plus progestin and the risk of coronary heart disease;Manson;N Engl J Med,2003

5. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial;Wassertheil-Smoller;JAMA,2003

Cited by 260 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormone replacement therapy and cancer mortality in women with 17 site-specific cancers: a cohort study using linked medical records;British Journal of Cancer;2024-06-24

2. Geschlechtsspezifische Aspekte beim Lungenkarzinom;Zeitschrift für Pneumologie;2024-04-23

3. Reproductive factors and risk of lung cancer among 300,000 Chinese female never-smokers: evidence from the China Kadoorie Biobank study;BMC Cancer;2024-03-26

4. Managing menopause after cancer;The Lancet;2024-03

5. G protein-coupled estrogen receptor activates PI3K/AKT/mTOR signaling to suppress ferroptosis via SREBP1/SCD1-mediated lipogenesis;Molecular Medicine;2024-02-21